An Update on Pharmacological Relevance and Chemical Synthesis of Natural Products and Derivatives with Anti SARS‐CoV‐2 Activity
Open Access
- 8 November 2021
- journal article
- review article
- Published by Wiley in ChemistrySelect
- Vol. 6 (42) , 11502-11527
Abstract
Natural products recognized traditionally as a vital source of active constituents in pharmacotherapy. The COVID‐19 infection caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is highly transmissible, pathogenic, and considered an ongoing global health emergency. The emergence of COVID‐19 globally and the lack of adequate treatment brought attention towards herbal medicines, and scientists across the globe instigated the search for novel drugs from medicinal plants and natural products to tackle this deadly virus. The natural products rich in scaffold diversity and structural complexity are an excellent source for antiviral drug discovery. Recently the investigation of several natural products and their synthetic derivatives resulted in the identification of promising anti SARS‐CoV‐2 agents. This review article will highlight the pharmacological relevance and chemical synthesis of the recently discovered natural product and their synthetic analogs as SARS‐CoV‐2 inhibitors. The summarized information will pave the path for the natural product‐based drug discovery of safe and potent antiviral agents, particularly against SARS‐CoV‐2.Keywords
This publication has 197 references indexed in Scilit:
- Novel antiviral activity of baicalein against dengue virusBMC Complementary and Alternative Medicine, 2012
- A Historical Overview of Natural Products in Drug DiscoveryMetabolites, 2012
- Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor AxisCancer Research, 2010
- Damage of Streptococcus mutans biofilms by carolacton, a secondary metabolite from the myxobacterium Sorangium cellulosumBMC Microbiology, 2010
- Drug Discovery and Natural Products: End of an Era or an Endless Frontier?Science, 2009
- Natural products in drug discoveryDrug Discovery Today, 2008
- Synthesis of Antiproliferative Cephalotaxus Esters and Their Evaluation against Several Human Hematopoietic and Solid Tumor Cell Lines: Uncovering Differential Susceptibilities to Multidrug ResistanceChemistry – A European Journal, 2008
- Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and TrialsCell, 2007
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006